🔍 Definition
Myocardial infarction (MI) is defined as acute myocardial injury with clinical evidence of acute myocardial ischemia, consistent with the Fifth Universal Definition of Myocardial Infarction (2026) jointly issued by the European Society of Cardiology (ESC), American College of Cardiology (ACC), American Heart Association (AHA), and World Heart Federation (WHF). The hallmark remains detection of a rise and/or fall of cardiac troponin (cTn) with values above the 99th percentile upper reference limit (URL), interpreted with ischemic symptoms, new ECG changes, imaging evidence of new loss of viable myocardium, angiographic findings, or other objective evidence of acute myocardial ischemia.
MI is broadly categorized by mechanism. Type 1 MI results from spontaneous atherosclerotic plaque rupture, erosion, or fissuring with intraluminal thrombus formation in one or more coronary arteries, leading to decreased myocardial blood flow. Type 2 MI occurs secondary to a mismatch between myocardial oxygen supply and demand without coronary plaque rupture — for example, in the setting of sepsis, severe anemia, hypotension, or sustained tachyarrhythmia. Type 3 describes fatal MI when biomarker evidence is unavailable; Types 4a, 4b, and 4c are PCI-related categories, including PCI-related MI, stent thrombosis, and restenosis; and Type 5 is CABG-related MI.
Electrocardiographically, MI is classified as ST-elevation MI (STEMI) when persistent ST-segment elevation is present, reflecting complete coronary occlusion requiring immediate reperfusion therapy, or non-ST-elevation MI (NSTEMI), where the artery is partially occluded. The FY2027 ICD-10-CM classification includes specific codes for STEMI by anatomical wall, NSTEMI, Type 2 MI, other MI types, MI with coronary microvascular dysfunction, and subsequent infarctions occurring within 28 days.
Under FY2027 ICD-10-CM Official Guidelines (Section I.C.9.e), code I21.9 (Acute myocardial infarction, unspecified) is the default for unspecified acute MI or unspecified type. Code I21.4 is used for provider-documented type 1 NSTEMI and nontransmural MI. Do not infer NSTEMI from biomarkers and absence of ST elevation alone without provider documentation; query for MI type when clinically appropriate.
🗂️ Alternative Terminology
Multiple lay and clinical terms are used interchangeably for myocardial infarction, which can create documentation ambiguity for coders and CDI specialists.
| Formal / Clinical Term | Colloquial / Lay / Synonymous Terms |
|---|---|
| Myocardial infarction (MI) | Heart attack, cardiac infarction |
| STEMI (ST-elevation MI) | Transmural MI, full-thickness MI, Q-wave MI (older), “massive heart attack” |
| NSTEMI (Non-ST-elevation MI) | Subendocardial MI, partial-thickness MI, non-Q-wave MI (older), “mild heart attack” |
| Type 1 MI | Spontaneous MI, ACS-related MI, plaque rupture MI, thrombotic MI |
| Type 2 MI | Demand ischemia MI, supply-demand mismatch MI, secondary MI |
| Type 2 MI | MI due to demand ischemia, MI secondary to ischemic imbalance |
| Type 3 MI | Fatal MI without biomarker confirmation, sudden cardiac death with presumed MI |
| Type 4a MI | PCI-related MI, post-angioplasty MI, periprocedural MI |
| Type 4b MI | In-stent thrombosis MI, stent thrombosis infarction |
| Type 4c MI | PCI restenosis MI, in-stent restenosis MI, restenosis after balloon angioplasty |
| Type 5 MI | CABG-related MI, post-bypass MI |
| Subsequent MI (I22.x) | Recurrent MI, reinfarction, repeat heart attack (within 28 days) |
| Old/healed MI (I25.2) | Prior MI, remote MI, history of heart attack, silent MI (incidental ECG finding) |
| Acute coronary syndrome (ACS) | Umbrella term: includes STEMI, NSTEMI, and unstable angina |
| MINOCA | MI with non-obstructive coronary arteries (no culprit plaque ≥50%) |
🩺 Signs & Symptoms
Classic presentation includes crushing, pressure-like substernal chest pain radiating to the left arm, jaw, or shoulder, often accompanied by diaphoresis, nausea, and dyspnea. However, atypical presentations are common, particularly in women, elderly patients, and diabetics, who may present with epigastric pain, fatigue, or syncope without classic chest pain.
- Chest pain / pressure: Onset usually at rest or with exertion; typically >20 minutes duration; not relieved by nitroglycerin
- Radiation: Left arm, jaw, neck, back, or right arm
- Diaphoresis: Cold sweat, pallor
- Dyspnea: Particularly in anterior STEMI with LV dysfunction
- Nausea/vomiting: More common in inferior MI (RCA distribution)
- Syncope or presyncope: Due to hemodynamic compromise or arrhythmia
- Palpitations: Ventricular ectopy, VT, VF common with acute ischemia
- Silent MI: Asymptomatic, detected only on ECG or imaging (common in diabetics)
- ECG findings: ST elevation (STEMI), ST depression/T-wave inversion (NSTEMI), new LBBB, pathological Q-waves
- Biomarkers: Elevated cardiac troponin I or T above 99th percentile URL; CK-MB elevation
Elevated troponin alone does NOT equate to MI. Per the 4th Universal Definition, troponin elevation without ischemic evidence constitutes myocardial injury (coded I5A), not MI. The provider must explicitly document which condition is present — Type 1 MI, Type 2 MI, or non-ischemic myocardial injury — to support accurate code assignment.
🧭 Differential Diagnosis
Chest pain with troponin elevation requires systematic exclusion of the following conditions before assigning a myocardial infarction code.
| Condition | Key Differentiating Features | ICD-10-CM Code |
|---|---|---|
| Unstable angina | Chest pain, ECG changes, but troponin negative or below 99th percentile URL | I20.0 |
| Non-ischemic myocardial injury | Elevated troponin without ischemic symptoms, ECG, or imaging changes (e.g., sepsis) | I5A |
| Acute pericarditis | Pleuritic, positional chest pain; diffuse ST elevation; pericardial rub | I30.9 |
| Aortic dissection | Tearing/ripping pain; BP differential; widened mediastinum on CXR | I71.00; I71.010–I71.019; I71.02; I71.03 |
| Pulmonary embolism | Sudden dyspnea, pleuritic pain, hypoxia, right heart strain on ECG; D-dimer elevated | I26.09, I26.99 |
| Takotsubo cardiomyopathy | Apical ballooning on echo; triggered by emotional/physical stress; predominantly women | I51.81 |
| Myocarditis | Diffuse ST elevation, viral prodrome, younger patients, normal coronary angiogram | I40.9 |
| GERD / esophageal spasm | Relieved by antacids/nitroglycerin; normal troponin/ECG; worse postprandially | K21.0, K22.4 |
| Demand ischemia without MI | Supply-demand ischemia without infarction; if troponin elevation is non-ischemic injury, provider must distinguish injury from infarction | I24.89 or I5A |
📋 Clinical Indicators
Documentation must support the specific MI type and ECG classification to justify code assignment. The following indicators directly drive code selection and CC/MCC designation.
| Clinical Indicator | Code Impact | Documentation Needed |
|---|---|---|
| ST elevation on ECG by wall location | I21.01–I21.29 (STEMI anterior/inferior/other) | ECG report with specific wall; cardiologist note |
| No ST elevation; troponin positive | I21.4 (NSTEMI) | Provider documentation of NSTEMI; ECG; troponin values |
| Type 2 MI / demand ischemia / supply-demand mismatch | I21.A1 + underlying cause code | Explicit provider statement; cause identified (sepsis, hemorrhage, anemia, tachycardia) |
| MI within 28 days of prior MI | I22.x + I21.x; I22 sequenced first if current encounter | Dates of both infarctions; type of current MI |
| MI > 28 days ago, no current acute event | I25.2 (old/healed MI) | Prior history documented; no acute management in current encounter |
| STEMI converted to NSTEMI by thrombolytics | I21.0–I21.3 (still coded as STEMI) | Per ICD-10-CM guideline I.C.9.e.1; code STEMI even after thrombolytic conversion |
| PCI-related MI (Type 4a/4b/4c) | I21.A9 | Procedure note; post-PCI biomarker criteria and supporting clinical/angiographic findings; specify Type 4a, 4b, or 4c when documented |
| Post-CABG MI (Type 5) | I21.A9 | cTn >10x URL; new Q-wave or graft occlusion on angiography |
| Troponin elevated, no ischemia documented | I5A (myocardial injury — NOT MI) | Provider must explicitly distinguish injury from infarction |
When the chart documents elevated troponin in the setting of sepsis, tachycardia, severe anemia, or hemorrhagic shock without explicit MI diagnosis, query the provider: “The record reflects elevated cardiac troponin in the setting of [clinical condition]. Based on your clinical judgment, would you please clarify whether this represents: (a) Type 2 myocardial infarction (demand ischemia/supply-demand mismatch), (b) non-ischemic myocardial injury, (c) Type 1 myocardial infarction (plaque rupture), or (d) other, please specify?” This query is critical — Type 2 MI maps to HCC 228 and MCC status; non-ischemic myocardial injury (I5A) does not.
🦴 Anatomy & Pathophysiology
The coronary circulation consists of the left main coronary artery (LMCA), which bifurcates into the left anterior descending (LAD) and left circumflex (LCx) arteries, and the right coronary artery (RCA). In right-dominant anatomy (~85% of patients), the RCA supplies the posterior descending artery (PDA). The LAD supplies the anterior wall and apex; the LCx supplies the lateral wall; the RCA supplies the inferior wall and right ventricle.
Type 1 MI pathophysiology begins with vulnerable plaque rupture or erosion within a coronary artery. Exposure of subendothelial collagen triggers platelet aggregation and thrombin generation, forming an acute thrombus that partially or completely occludes the lumen. Complete occlusion typically produces STEMI; partial occlusion produces NSTEMI. Ischemia progresses from subendocardium outward (wavefront phenomenon), with irreversible necrosis beginning within 20–40 minutes of complete ischemia and completing within 4–6 hours. Reperfusion by PCI or thrombolytics within this window salvages at-risk myocardium.
Type 2 MI pathophysiology involves supply-demand mismatch without plaque rupture. Reduced oxygen supply (severe anemia, hypotension, respiratory failure, coronary spasm) or increased demand (sustained tachyarrhythmia, severe hypertension) exceeds myocardial oxygen delivery capacity in the setting of fixed or dynamic coronary stenoses. This mechanism accounts for an estimated 25–30% of all MI presentations and carries distinct management implications per the ACC’s summary of the 4th Universal Definition.
Infarction consequences include myocyte necrosis, ventricular remodeling, reduced ejection fraction, susceptibility to arrhythmia (VT/VF in first 24 hours), mechanical complications (papillary muscle rupture, free wall rupture, VSD), and longer-term heart failure if significant myocardium is lost.
💊 Medication Impact / Treatment
Pharmacologic management directly affects clinical trajectory and should be documented specifically to support CDI accuracy regarding complications (e.g., bleeding from anticoagulation) and acuity.
- Antiplatelet therapy: Aspirin (325 mg load, 81 mg maintenance) + P2Y12 inhibitor (ticagrelor, clopidogrel, prasugrel) — dual antiplatelet therapy (DAPT) is standard for ACS per 2025 ACC/AHA ACS Guidelines. Duration: 12 months post-stent for most patients.
- Anticoagulation: Unfractionated heparin (UFH), low-molecular-weight heparin (enoxaparin), bivalirudin, or fondaparinux during acute phase. Bleeding complications should be specifically documented and coded.
- Thrombolytics: Alteplase, tenecteplase — indicated for STEMI when PCI not available within 120 minutes. Administration of tPA warrants Z92.82 (status post administration of tPA in a different facility within last 24 hours) when applicable.
- Beta-blockers: Metoprolol, carvedilol — reduce mortality, prevent remodeling. Contraindicated in acute decompensated HF or cardiogenic shock.
- ACE inhibitors / ARBs: Lisinopril, ramipril — indicated for all MI patients with LVEF ≤40%, hypertension, or diabetes.
- Statins: High-intensity statin (atorvastatin 80 mg, rosuvastatin 40 mg) initiated in all MI patients regardless of baseline LDL.
- Nitrates: Sublingual or IV nitroglycerin for ongoing ischemic pain; withhold in right ventricular infarction (inferior STEMI with RV involvement).
- Mineralocorticoid receptor antagonists: Eplerenone/spironolactone post-MI with LVEF ≤40% and HF or diabetes.
- GLP-1 receptor agonists / SGLT2 inhibitors: Added post-MI in patients with diabetes for secondary prevention per updated guidelines.
Type 2 MI management focuses on treating the underlying cause (e.g., sepsis, hemorrhage, tachycardia) rather than emergent PCI. Antiplatelet agents and heparin may be inappropriate or even contraindicated. Coders must not assume PCI was performed for Type 2 MI — query if a cardiac catheterization or PCI is documented alongside a Type 2 MI diagnosis to clarify whether the procedure was therapeutic or diagnostic.
Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO CDG members.
📘 ICD-10-CM Guidelines
The following guidelines apply per the FY2027 ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.9.e (Acute myocardial infarction).
Guideline I.C.9.e.1 — STEMI/NSTEMI Classification
Code I21.3 (STEMI of unspecified site) is the default when STEMI is documented without a specific wall location. If the provider documents “acute MI” without specifying STEMI or NSTEMI, code I21.9 (Acute myocardial infarction, unspecified). If NSTEMI evolves to STEMI, code the STEMI. If STEMI converts to NSTEMI due to thrombolytic therapy, still code the STEMI — the thrombolytic conversion does not change the original classification.
Guideline I.C.9.e.2 — Acute MI and Duration
Category I21 codes are used for MIs documented as acute or with a stated duration of 4 weeks (28 days) or less. For encounters after the 4-week time frame when the patient is still receiving care related to the MI, assign the appropriate aftercare code rather than a category I21 code. Code I25.2 (Old myocardial infarction) is used for old or healed MI not requiring further care.
Guideline I.C.9.e.3 — Subsequent Acute MI (Category I22)
When a patient suffers a new MI within 28 days of an initial MI, use a code from category I22 (Subsequent ST elevation [STEMI] and non-ST elevation [NSTEMI] myocardial infarction) together with the category I21 code. Sequencing depends on the encounter circumstance — if the patient is seen primarily for the subsequent MI, I22 is sequenced as principal diagnosis. The I22 category applies only to subsequent Type 1 MI or unspecified MI. For a second occurrence of Type 2 MI within 28 days, report only I21.A1 (not I22). For Type 4 or Type 5 within 28 days, code only I21.A9.
I22 codes are not to be used for MI types other than Type 1 or unspecified. Assigning I22.x for a Type 2 MI (I21.A1) occurring within 28 days of a prior MI is a CMS coding error. The I22 Excludes1 note explicitly states: “subsequent myocardial infarction, type 2 (I21.A1)” and “subsequent myocardial infarction of other type (type 3)(type 4)(type 5)(I21.A9)” as exclusions from the I22 category.
Guideline I.C.9.e.4 — Type 2 MI Sequencing
Per ICD-10-CM guidance on Type 2 MI and AHA Coding Clinic direction, when a Type 2 MI occurs in the setting of another condition (e.g., sepsis, GI hemorrhage, severe anemia), sequencing follows the principal diagnosis rule. If sepsis is the principal diagnosis and Type 2 MI is a complication, the underlying condition is sequenced first, followed by I21.A1 with an additional code for the underlying cause. If the Type 2 MI is the reason for the encounter, I21.A1 may be the principal diagnosis, with an additional code for the precipitating condition.
Guideline I.C.9.e.6 — I21.B (Coronary Microvascular Dysfunction)
Code I21.B captures myocardial infarction with coronary microvascular dysfunction. Assign I21.B for MI with coronary microvascular disease, MI with coronary microvascular dysfunction, or MINOCA with microvascular disease when explicitly documented. Do not assign I21.B for Takotsubo syndrome, coronary spasm, or non-obstructive coronary arteries alone unless the provider documents MI with coronary microvascular dysfunction. Verify MS-DRG severity against the FY2027 MS-DRG v44.0 logic.
🔢 ICD-10-CM Code Set (Tabular)
| Code | Description | Type | Notes / CC-MCC |
|---|---|---|---|
| I21.01 | STEMI — left main coronary artery | Type 1 STEMI | MCC; highest-risk anatomy |
| I21.02 | STEMI — left anterior descending (LAD) | Type 1 STEMI | MCC; anterior wall (most common) |
| I21.09 | STEMI — other coronary artery, anterior wall | Type 1 STEMI | MCC; diagonal or septal branches |
| I21.11 | STEMI — right coronary artery (RCA) | Type 1 STEMI | MCC; inferior wall; right dominant |
| I21.19 | STEMI — other coronary artery, inferior wall | Type 1 STEMI | MCC; posterior descending or obtuse marginal |
| I21.21 | STEMI — left circumflex artery | Type 1 STEMI | MCC; lateral/posterior wall |
| I21.29 | STEMI — other site | Type 1 STEMI | MCC; lateral, posterior, or right ventricular MI |
| I21.3 | STEMI — unspecified site | Type 1 STEMI | MCC; use when location not documented |
| I21.4 | NSTEMI | Type 1 NSTEMI | MCC; partial occlusion; troponin +; no ST elevation |
| I21.9 | Acute MI, unspecified | Unspecified | MCC; query for specificity; STEMI/NSTEMI preferred |
| I21.A1 | Myocardial infarction Type 2 | Type 2 (demand) | MCC; code additional cause (sepsis, anemia, etc.); not due to plaque rupture |
| I21.A9 | Other MI types (Types 3, 4a, 4b, 4c, 5) | Types 3–5 | MCC; includes procedure-related and fatal MI |
| I21.B | MI with coronary microvascular dysfunction | MINOCA-related | MCC; MI with coronary microvascular disease/dysfunction or MINOCA with microvascular disease; requires explicit documentation |
| I22.0 | Subsequent STEMI — anterior wall | Subsequent Type 1 | MCC; use with I21.x; within 28 days |
| I22.1 | Subsequent STEMI — inferior wall | Subsequent Type 1 | MCC; use with I21.x; within 28 days |
| I22.2 | Subsequent NSTEMI | Subsequent Type 1 | MCC; use with I21.x; within 28 days |
| I22.8 | Subsequent STEMI — other site | Subsequent Type 1 | MCC; use with I21.x; lateral/posterior |
| I22.9 | Subsequent STEMI — unspecified site | Subsequent Type 1 | MCC; use with I21.x; when location not documented |
| I25.2 | Old/healed MI | History | No HCC weight; >28 days old; history/comorbidity coding |
| I5A | Non-ischemic myocardial injury | NOT MI | Not MI — elevated troponin without ischemia evidence |
| Z92.82 | Status post tPA in different facility, last 24 hours | Add-on | Use when patient transferred after tPA administration elsewhere |
Code I21.B (Myocardial infarction with coronary microvascular dysfunction) remains active in FY2027. It is appropriate when the provider explicitly documents MI with coronary microvascular disease, MI with coronary microvascular dysfunction, or MINOCA with microvascular disease. Do NOT assign I21.B based on an absence of obstructive disease on angiogram alone — that alone supports MINOCA workup, not the diagnosis of MI with coronary microvascular dysfunction.
🔎 Indexing
Use the ICD-10-CM Alphabetic Index under the main term Infarct, infarction → myocardium, myocardial to locate codes. Key index pathways include:
- Infarct, infarction → myocardium → acute → ST elevation (STEMI) → anterior (anteroapical) (anterolateral) (anteroseptal) (Q wave) (wall) → involving left anterior descending coronary artery → I21.02
- Infarct → myocardium → acute → ST elevation → inferior (wall) → I21.11 (RCA) or I21.19 (other)
- Infarct → myocardium → acute → non-ST elevation (NSTEMI) → I21.4
- Infarct → myocardium → type 2 → I21.A1
- Infarct → myocardium → due to demand ischemia → I21.A1 (cross-references to Type 2)
- Infarct → myocardium → subsequent → I22.x
- Infarct → myocardium → old → I25.2
- Infarct → myocardium → healed or old → I25.2
- Infarction → myocardium → with coronary microvascular dysfunction → I21.B
- Injury, myocardial, non-ischemic → I5A (non-ischemic myocardial injury)
Tabular verification note: Always verify instructional notes in the I21 Tabular. The category carries “Use additional code, if applicable, for: exposure to tobacco smoke (Z77.22), tobacco dependence (F17.-), status post tPA (Z92.82).” The I21.A1 guidance requires the underlying cause to be coded first, if applicable — failure to capture the precipitating condition for Type 2 MI represents an incomplete code set.
🏥 CPT
Procedure coding for myocardial infarction spans diagnostic (ECG, cardiac catheterization) and therapeutic (PCI, CABG) services. The following codes reflect AMA CPT 2027. Global period rules apply to all surgical procedures.
| CPT Code(s) | Description | Global Period | Notes |
|---|---|---|---|
| 93000 | Electrocardiogram (ECG/EKG), routine with at least 12 leads; with interpretation and report | 0 days | Essential first diagnostic step for MI evaluation |
| 93005 | ECG tracing only (no interpretation) | 0 days | Technical component only; hospital outpatient or ED facility |
| 93010 | ECG interpretation and report only | 0 days | Professional component only; cardiologist read |
| 93451 | Right heart catheterization, hemodynamic assessment | 0 days | Pulmonary artery catheter; Swan-Ganz; measures PCWP, CO |
| 93454 | Coronary artery angiography (catheter-based), all views | 0 days | Diagnostic cath only; no intervention |
| 93455 | Coronary artery angiography with bypass graft angiography | 0 days | Diagnostic coronary and bypass graft angiography; does not include right heart catheterization |
| 93461 | Coronary artery and bypass graft angiography with right and left heart catheterization, including left ventriculography when performed | 0 days | Full diagnostic cath with hemodynamic assessment, LV function when performed, and bypass graft angiography |
| 93464 | Physiologic exercise treadmill test during cath | 0 days | Rarely used in acute MI; elective/stable CAD evaluation |
| 92920 | Percutaneous transluminal coronary angioplasty (PTCA), single major epicardial vessel | 0 days | Balloon angioplasty; often bundled with stenting |
| 92928 | Percutaneous coronary stent placement, single vessel | 0 days | Most common primary PCI for STEMI; drug-eluting stent |
| 92929 | Each additional coronary stent, same vessel | 0 days | Add-on code; report with 92928 |
| 92933 | Coronary atherectomy with stent placement, single vessel | 0 days | Rotational or orbital atherectomy prior to stenting |
| 92941 | Percutaneous coronary intervention, acute MI (includes PTCA/stent) | 0 days | Specific acute MI PCI code — use when PCI is performed in context of acute MI |
| 92943 | PCI, chronic total occlusion (CTO), single vessel | 0 days | CTO PCI post-MI; non-culprit vessel |
| 92972 | Percutaneous transluminal coronary lithotripsy | ZZZ | Add-on; report once per major coronary artery or bypass graft when performed with an appropriate PCI code |
| 92976 | Percutaneous transcatheter therapeutic drug-delivery by intracoronary drug-delivery balloon, single major artery and/or branches | ZZZ | New CPT 2027 add-on; report once per major coronary artery or bypass graft; do not report with 92920 |
| 92944 | Each additional vessel or branch, PCI | 0 days | Multivessel PCI add-on code |
| 33510 | CABG, venous graft, single vessel | 90 days | Bypass surgery using vein graft; urgent/elective |
| 33511–33516 | CABG, venous grafts, 2–6 vessels | 90 days | Increment by vessel count; most MI CABG uses 3–4 grafts |
| 33517–33523 | CABG, arterial grafts (LIMA, RIMA, radial artery), various combos | 90 days | LIMA to LAD is gold standard; add-on arterial codes combine with venous |
| 33534–33536 | CABG, arterial graft only, 1–3+ vessels | 90 days | All-arterial bypass; less common |
- 92976: new for CPT 2027; not reportable for 2026 dates of service.
CABG procedures (CPT 33510–33536) carry a 90-day global period. Any E/M visit, cardiac catheterization, or procedure performed within 90 days post-CABG by the same surgeon is included in the global package unless an unrelated condition is treated. Separate billing is allowed for a new MI (unrelated to the surgical procedure) occurring within the global period. Use modifier -24 (unrelated E/M during global period) or -79 (unrelated procedure) as applicable. Diagnostic coronary angiography performed at a separate session from a coronary interventional procedure is separately reportable; diagnostic angiography performed during the same interventional session is separately reportable only when CPT criteria are met and documentation supports medical necessity.
🧾 HCPCS
| HCPCS Code | Description | Typical Use / Payer Applicability |
|---|---|---|
| A9552 | Fluorodeoxyglucose F-18 FDG (18F-FDG PET radiotracer), per study dose | PET perfusion/viability imaging post-MI; determines hibernating vs. infarcted myocardium; Medicare covered with diagnosis |
| C1874 | Stent, coated/covered, with delivery system | Drug-eluting stent (DES) — outpatient facility only (OPPS); pass-through or APC payment; not reported by physician |
| C1875 | Stent, coated/covered, without delivery system | Drug-eluting stent without delivery system; outpatient facility billing |
| C1876 | Stent, non-coated/non-covered, with delivery system | Bare metal stent (BMS) — outpatient facility; rarely used post-MI in contemporary practice |
| C2623 | Catheter, transluminal angioplasty, drug-coated, non-laser | Drug-coated balloon for in-stent restenosis post-PCI |
| G9793 | Patient is currently on a daily aspirin or other antiplatelet | MIPS quality data code for applicable vascular disease/secondary-prevention measures; verify current measure specifications and payer requirements |
| Q3014 | Telehealth originating site facility fee | Remote cardiac monitoring post-MI; eligible sites per CMS |
HCPCS C-codes for stents (C1874–C1876) are reported only by the outpatient facility (hospital) on the UB-04 claim form under the Outpatient Prospective Payment System (OPPS). Physician/professional claims (CMS-1500) do not report C-codes — the physician bills the corresponding CPT procedure code (e.g., 92928 for stent placement). For inpatient stays, stent supply costs are included in the MS-DRG payment — no separate device code applies on the IP claim.
📚 AHA Coding Clinic
The following summarizes key AHA Coding Clinic advisories relevant to myocardial infarction coding:
| Coding Clinic Issue | Topic | Guidance Summary |
|---|---|---|
| 4th Qtr 2017 / 1st Qtr 2018 | Introduction of Type 2 MI code (I21.A1) | Code I21.A1 is reported when the physician explicitly documents “Type 2 MI,” “demand ischemia MI,” or “MI secondary to ischemic imbalance.” An additional code should be assigned for the underlying condition causing the supply-demand mismatch (e.g., A41.9 sepsis, D62 acute blood loss anemia, I48.91 tachyarrhythmia). |
| 2018–2019 | Troponin elevation in sepsis — MI vs. injury | When a patient with sepsis has elevated troponin, the physician must distinguish Type 2 MI from non-ischemic myocardial injury (I5A). Without explicit documentation of ischemic symptoms, ECG changes, or imaging evidence, code I5A — not I21.A1. CDI query is appropriate per clinical guidance. |
| Recent guidance (2022–2024) | Type 2 MI sequencing with sepsis | When a patient presents with sepsis as the principal diagnosis and develops Type 2 MI as a complication, the sepsis code (A41.x) is sequenced first per UHDDS principal diagnosis selection rules; I21.A1 is an additional diagnosis. If the Type 2 MI is the primary reason for admission, I21.A1 is principal and the underlying cause is additional. |
| Ongoing guidance | STEMI/NSTEMI conversion by thrombolytics | Code STEMI (I21.0x–I21.3) even when the patient was administered thrombolytics and the ST elevation resolved before PCI or hospital arrival. The original STEMI designation is maintained per ICD-10-CM Guideline I.C.9.e.1. |
| Ongoing guidance | I22 — Subsequent MI coding rules | I22.x applies only to subsequent Type 1 or unspecified MI within 28 days. It does not apply to Type 2, 3, 4, or 5 MI. For a subsequent Type 2 MI, assign only I21.A1 without an I22 code. |
| FY2022 guidance | Code I21.B — MI with microvascular dysfunction | I21.B requires explicit provider documentation of MI with coronary microvascular dysfunction. MINOCA (MI with non-obstructive coronaries on angiogram) alone is insufficient — the provider must specify microvascular dysfunction as the mechanism. |
💰 HCC / Risk Adjustment
Under CMS-HCC Model v28, fully operative since payment year 2026 and continuing in the PY 2027 initial mappings, acute myocardial infarction maps to HCC 228 (Acute Myocardial Infarction). This replaces the prior V24 structure where AMI mapped to HCC 86.
| ICD-10-CM Code | HCC v28 Category | HCC Name | RAF Coefficient (Community, NonDual, Aged) | Risk Adjustment Impact |
|---|---|---|---|---|
| I21.01–I21.29, I21.3 (STEMI) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Significant RAF impact; MCC in DRG logic |
| I21.4 (NSTEMI) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Same HCC as STEMI in v28 (consolidated) |
| I21.9 (AMI unspecified) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Prefer specific code for clinical accuracy |
| I21.A1 (Type 2 MI) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Captures same HCC as Type 1 — critical to document explicitly |
| I21.A9 (Other MI types) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Procedure-related MI; HCC captured if documented |
| I22.x (Subsequent MI) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Subsequent MI still captures HCC 228 |
| I25.2 (Old/healed MI) | None in v28 | — | 0 | No HCC value; history only; no RAF contribution |
| I21.B (MI + microvascular) | HCC 228 | Acute Myocardial Infarction | ~0.252 | Same HCC; MCC in DRG; RAF impact present |
Key v28 note: Under HCC v28, STEMI and NSTEMI are consolidated into a single HCC 228 (Acute Myocardial Infarction). As confirmed by the CMS-HCC v28 code list, HCC 228 captures all I21.x acute MI codes. The RAP coefficient of approximately 0.252 for a community, non-dual, aged beneficiary reflects meaningful reimbursement impact in Medicare Advantage. V28 is 100% operative for payment year 2026, replacing the prior phase-in approach.
For Medicare Advantage patients with documented elevated troponin and demand ischemia but no explicit MI diagnosis, a compliant CDI query should clarify whether the clinical picture represents Type 2 MI (I21.A1 → HCC 228, RAF ~0.252) vs. non-ischemic myocardial injury (I5A → no HCC). This distinction directly affects Medicare Advantage payment. Ensure the diagnosis is documented, supported, and reported at least once during the applicable risk-adjustment data-reporting period when clinically present; do not repeat an acute MI diagnosis on later encounters unless it remains an active acute condition.
✍️ CDI Query Templates
All queries below are compliant with ACDIS and AHIMA query guidelines — non-leading, multiple-choice format, presented as a request for clinical judgment, not a directive to change a diagnosis.
| Clinical Scenario | Query Wording (Multiple Choice) |
|---|---|
| Elevated troponin in setting of sepsis — MI type unclear | “Patient presents with sepsis and elevated cardiac troponin above the 99th percentile. Based on your clinical assessment, does this represent: (a) Type 2 myocardial infarction (supply-demand mismatch/demand ischemia), (b) non-ischemic myocardial injury, (c) Type 1 myocardial infarction (acute coronary syndrome/plaque rupture), (d) clinically undetermined, or (e) other: __________?” |
| STEMI documentation without wall location specified | “The record documents ST elevation myocardial infarction (STEMI). Based on the ECG findings and/or cardiac catheterization report, can you clarify the infarction location: (a) anterior wall (LAD or diagonal), (b) inferior wall (RCA or PDA), (c) lateral wall (LCx or obtuse marginal), (d) posterior wall, (e) right ventricular infarction, or (f) location not determinable?” |
| Troponin positive — NSTEMI vs. unstable angina | “The record reflects chest pain with ECG changes and a troponin value of [X]. Based on your clinical judgment, does this represent: (a) NSTEMI (non-ST elevation myocardial infarction), (b) unstable angina, (c) Type 2 myocardial infarction, (d) non-ischemic myocardial injury, or (e) other: __________?” |
| Troponin elevation post-PCI — procedural MI? | “The patient’s post-PCI troponin is elevated at [X] times the 99th percentile URL. Based on your clinical assessment, does this represent: (a) Type 4a MI (periprocedural MI related to PCI), (b) expected post-procedural troponin elevation without infarction, (c) Type 1 MI (separate from the procedure), (d) non-ischemic myocardial injury, or (e) clinically undetermined?” |
| Documentation of “demand ischemia” without MI qualifier | “The record documents ‘demand ischemia’ in the clinical assessment. For coding and clinical documentation purposes, does this represent: (a) Type 2 myocardial infarction (with ischemic evidence meeting MI criteria), (b) myocardial ischemia without infarction, (c) non-ischemic myocardial injury, or (d) other: __________? If Type 2 MI, please also document the primary underlying cause (e.g., sepsis, hemorrhagic shock, sustained tachyarrhythmia, severe anemia).” |
| Second cardiac event within 28 days | “The record reflects a new acute MI event occurring within 28 days of the initial MI. Please clarify the type of the current MI: (a) STEMI — anterior wall, (b) STEMI — inferior wall, (c) NSTEMI (Type 1), (d) Type 2 MI (demand ischemia), (e) Type 4/5 (procedure-related), or (f) clinically undetermined?” |
🧑⚕️ Treatments (Clinical)
Clinical management of MI is time-dependent and varies by MI type. Coders and CDI specialists must understand the treatment context to evaluate whether additional diagnoses (HF, shock, arrhythmia) are present and appropriately documented.
STEMI (Type 1)
- Primary PCI (pPCI): Goal door-to-balloon ≤90 minutes; preferred reperfusion strategy per 2025 ACC/AHA ACS Guidelines. Drug-eluting stent preferred over bare metal stent.
- Fibrinolysis: When pPCI not available within 120 minutes; tenecteplase (TNK) or alteplase (tPA); contraindicated with prior hemorrhagic stroke, active bleeding, severe HTN.
- Anticoagulation: Unfractionated heparin, bivalirudin, or enoxaparin during PCI.
- DAPT: Aspirin + ticagrelor (preferred) or clopidogrel for 12 months post-stent.
- Beta-blockers: Oral metoprolol within 24 hours if hemodynamically stable; avoid in cardiogenic shock or reactive airway disease.
- ACE inhibitors: All STEMI patients, especially with LVEF <40%.
- Statins: High-intensity statin started before discharge.
NSTEMI (Type 1)
- Risk stratification: TIMI or GRACE score; high-risk patients proceed to early invasive strategy (cath within 24 hours).
- Anticoagulation + antiplatelet: Same as STEMI; PCI performed electively within 24–72 hours based on risk score.
- Medical management: Nitrates, beta-blockers, oxygen if hypoxic (SpO₂ <90%); statins; ACE inhibitors.
Type 2 MI (Demand Ischemia)
- Treat the underlying cause: Sepsis → antibiotics + fluid resuscitation; tachyarrhythmia → rate control; hemorrhage → transfusion; severe anemia → transfusion/iron.
- Cardiac catheterization: Generally not indicated acutely unless Type 1 cannot be excluded; individualized decision-making.
- Antiplatelet/anticoagulation: Risk-benefit assessment — may exacerbate bleeding if hemorrhage is the precipitating cause.
- Beta-blockers: May be used for rate control in tachycardia-driven Type 2 MI.
Cardiac Surgery (CABG)
- Indicated for left main stenosis, multivessel disease with LV dysfunction, or failed PCI.
- Emergency CABG for ongoing ischemia refractory to medical therapy and PCI.
- Cardioplegic arrest, on-pump or off-pump techniques; LIMA-to-LAD graft preferred for long-term patency.
- ICU care post-operatively; ventilator management; potential complications (sternal wound infection, stroke, low-output syndrome) should be specifically documented.
MS-DRG Mapping (FY2027)
Per the FY2027 Final Rule MS-DRG Relative Weights, AMI inpatient cases (without surgical procedure) map to MDC 05 (Diseases and Disorders of the Circulatory System):
| MS-DRG | Description | Relative Weight | Geo Mean LOS | Arith Mean LOS |
|---|---|---|---|---|
| 280 | Acute MI, Discharged Alive, With MCC | 1.6112 | 4.0 days | 5.3 days |
| 281 | Acute MI, Discharged Alive, With CC | 0.9183 | 2.3 days | 2.9 days |
| 282 | Acute MI, Discharged Alive, Without CC/MCC | 0.7378 | 1.7 days | 2.0 days |
| 283 | Acute MI, Expired, With MCC | 1.9615 | 3.2 days | 5.2 days |
| 284 | Acute MI, Expired, With CC | 0.7534 | 1.6 days | 2.2 days |
| 285 | Acute MI, Expired, Without CC/MCC | 0.5197 | 1.2 days | 1.4 days |
Important: Verify I21.x and I22.x severity impact in the FY2027 MS-DRG v44.0 Definitions Manual and applicable CC/MCC exclusion logic. Therefore, when AMI is a secondary diagnosis, it can elevate a case from DRG without CC/MCC to with MCC — a substantial weight increase. When AMI is the principal diagnosis on a medical case, the distinction between MCC (e.g., cardiogenic shock, mechanical ventilation) and CC (e.g., heart failure without shock, stable arrhythmia) among secondary diagnoses drives DRG 280 vs. 281 vs. 282. Cardiac catheterization or PCI during the same inpatient stay will reclassify the case to the cardiac catheterization DRG family (222–227) or PCI DRG (246–251), which typically carry higher relative weights.
🎓 Patient Education / Summary
This section provides plain-language content useful for patient education materials, discharge instructions, and CDI conversations with clinical staff about documentation expectations.
What Is a Heart Attack?
A heart attack (myocardial infarction) happens when blood flow to part of the heart muscle is suddenly blocked, causing the heart muscle to begin dying from lack of oxygen. The longer the blockage lasts, the more damage occurs. Prompt treatment — calling 911, reaching a hospital, and restoring blood flow — limits long-term damage.
STEMI vs. NSTEMI — What’s the Difference?
In a STEMI, the artery is completely blocked. This is a medical emergency requiring immediate reopening of the artery (usually by cardiac catheterization and stenting) within 90 minutes of hospital arrival. In an NSTEMI, the artery is partially blocked. It still requires urgent treatment, usually catheterization within 24–72 hours, but the timeline is slightly less urgent than STEMI.
Type 2 MI — A Different Kind of Heart Attack
A Type 2 MI occurs not from a blocked artery from plaque rupture, but because the heart had to work harder than its blood supply could support — for example, because of a severe infection (sepsis), very low blood pressure, or dangerously fast heart rate. Treatment focuses on fixing the underlying problem. It is important for patients and care teams to understand this distinction because the treatment approach differs significantly from a traditional heart attack.
After a Heart Attack — Key Medications
- Aspirin — blood thinner to prevent clots; take daily
- P2Y12 inhibitor (ticagrelor, clopidogrel) — another blood thinner; do not stop without consulting your cardiologist
- Beta-blocker — slows the heart rate and reduces strain
- ACE inhibitor — protects the heart from further damage
- Statin — cholesterol medication to prevent future heart attacks
Warning Signs — When to Call 911
Call 911 immediately for: chest pain or pressure lasting more than a few minutes; pain spreading to arm, jaw, neck, or back; sudden shortness of breath; cold sweat; nausea or lightheadedness. Do not drive yourself to the hospital.
Documentation Note for Clinical Staff
Accurate documentation of MI type (STEMI location, NSTEMI, Type 2 MI vs. myocardial injury), duration, precipitating cause, and any complications (HF, arrhythmia, cardiogenic shock) is essential for proper coding, quality reporting, and Medicare Advantage risk adjustment. When in doubt, the CDI team will send a compliant query to clarify — please respond with your best clinical judgment based on the total clinical picture.
Sources: Fourth Universal Definition of Myocardial Infarction, Thygesen et al., Circulation 2018 | FY2027 ICD-10-CM Official Guidelines, CMS/CDC | CMS MS-DRG v44.0 Definitions Manual | FY2027 MS-DRG Relative Weights Table | CMS-HCC Model V28 / PY2027 ICD-10-CM mappings, CMS | ACC 4th Universal Definition of MI Summary | AHA Coding Clinic | AMA CPT 2027
About this Guide
This Clinical Documentation Guide is published by CCO Academy and is intended for credentialed coding, CDI, and clinical documentation professionals. Content is updated for FY2027 ICD-10-CM (effective October 1, 2026) and CPT 2027 (effective January 1, 2027). All code assignments should be verified against the official ICD-10-CM Tabular List, AHA Coding Clinic, and applicable payer-specific policies. This guide does not constitute legal, medical, or compliance advice.
Last reviewed: April 2026 · Next scheduled review: October 2026 (FY2027 update)
Ready to turn this knowledge into a credential?
These Clinical Documentation Guides are a free companion to CCO’s paid training programs. Browse our full CCO Course, Blitz & Practice Exam Catalog — every core course, review blitz, practice exam, textbook, and free resource in one place — and find the perfect next step for your coding career.
CCO Hero
Know someone starting a medical coding career?
Share your personal CCO link. Your friend saves 20% on their first course or practice exam of $100 or more, and you earn 5% cash on their first enrollment over $100.
Become a CCO Hero